FundedIQ
Biotechnology

Scenic Biotech: Funding, Investors & Team (Sep 2026)

Scenic Biotech is a developer of a genomics and immunotherapy technologies created to unlock genetic suppressors as a new class of drug targets.The company's immunotherapy technologies tackle diseases on the genetic level and focuses on disease suppressing genes., it uses genomics to develop innovative therapies for patients affected by severe diseases.

www.scenicbiotech.com LinkedIn Amsterdam, Netherlands 11-50 employees
Biometrics Biotechnology Collaborative Consumption Life Science
Total raised
$30.8M
Rounds
1
Latest
Series A
Mar 2022

Scenic Biotech has raised $30.8M across 1 funding round on record, the most recent a Series A of $30.8M announced in Mar 2022.

That round is above the $8.0M median round size for Biotechnology companies tracked on FundedIQ over the last two years.

Scenic Biotech Company Profile and Key Stats

Total funding raised
$30.8M
across 1 round on record
Funding rounds on record
1
Latest funding round
Series A
$30.8M in Mar 2022
Employees
11-50
reported band
Headquarters
Amsterdam, Netherlands

Latest funding round on record: Mar 2022.

Scenic Biotech Funding Rounds

Date
Round
Amount
Series A
$30.8M

Scenic Biotech Founders and Leadership Team

Name
Role
Contact
Oscar Izeboud
CEO
Locked

Contact details for the Scenic Biotech team: 1 of 1 has an email address on file.

Start 14-day free trial →

Scenic Biotech Funding Compared to Other Biotechnology Startups

Segment
Companies
Median round
4,179
$8.0M
740
$5.0M
8,352
$15M

Scenic Biotech's latest round of $30.8M is above the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.

Funded Startups Like Scenic Biotech in Biotechnology and Amsterdam

Companies Similar to Scenic Biotech

The Protein Brewery is a high-tech company that specializes in developing and making animal-free- based…

Series B $20.5M

Leyden Labs aims to help people live their lives to the fullest. Its platform targets commonalities of viral…

Undisclosed round $45.4M

Onward is creating an Implantable Neuro-stimulation System (INS) that includes real-time motion feedback and…

Undisclosed round $47.8M

Scinvivo is a medical technology company. Scinvivo is involved in bladder cancer medical needs. They provide…

Undisclosed round

Revyve produces animal-free food ingredients from microorganisms. The company's premium ingredients include…

Series B $28.3M

Merus is dedicated to creating superior treatments for cancer patients and potentially finding a cure. Our…

Undisclosed round $300M

Salvia BioElectronics is dedicated to creating new neuromodulation devices to help treat migraines. They are…

Series B $60.0M

We are a clinical-stage pharmaceutical company discovering and developing therapies targeting mitochondrial…

Undisclosed round $5.7M

QurieGen is a biotechnology company that speeds up the process of finding and creating new drugs.

Pre-Seed $2.4M

Protix Biosystems is a biometrics company that offers a range of products which enable its customers to…

Undisclosed round $1.1M

QDI Systems is a startup company that engages in the development of advanced imaging devices for medical…

Undisclosed round $2.6M

BIMINI Biotech, a startup established in 2019 in Leiden, The Netherlands, focuses on creating groundbreaking…

Seed $3.1M

Scenic Biotech Funding FAQs

What does Scenic Biotech do?

Scenic Biotech is a developer of a genomics and immunotherapy technologies created to unlock genetic suppressors as a new class of drug targets.The company's immunotherapy technologies tackle diseases on the genetic level and focuses on disease suppressing genes., it uses genomics to develop innovative therapies for patients affected by severe diseases.

How much funding has Scenic Biotech raised?

Scenic Biotech has raised $30.8M across 1 round on record. The most recent is a Series A of $30.8M announced in Mar 2022.

When did Scenic Biotech last raise funding?

Scenic Biotech's most recent funding round on record is a Series A of $30.8M, announced in Mar 2022.

Who is the CEO of Scenic Biotech?

Oscar Izeboud is listed as CEO at Scenic Biotech.

Where is Scenic Biotech headquartered?

Scenic Biotech is based in Amsterdam, Noord-Holland, Netherlands.

How many employees does Scenic Biotech have?

Scenic Biotech is in the 11-50 employee band.

How does Scenic Biotech's funding compare to other Biotechnology startups?

Scenic Biotech's latest round of $30.8M is above the $8.0M median round size for Biotechnology companies on FundedIQ across 4,179 tracked companies over the last two years.

About FundedIQ's Scenic Biotech Funding Data

FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.

Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Scenic Biotech is left off this page rather than filled in.

14-day free trial · Cancel anytime

Know who just raised. Then know who to reach.

Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.

Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.